Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SylvainL
    Senior Member
    • Feb 2012
    • 180

    #1

    Two-way repeated-measures ANOVA?

    Dear all,

    A researcher came with this design of data and asked me which statistical test will be the most appropriate to see if the difference after treat ment between cells1 and cells2 is significant...

    Code:
    >mydata
        Cell Experiment Treatment Value
    1  Cell1          1 untreated  4.41
    2  Cell1          1   treated 17.60
    3  Cell1          2 untreated  4.10
    4  Cell1          2   treated 11.50
    5  Cell1          3 untreated  5.21
    6  Cell1          3   treated  7.84
    7  Cell2          1 untreated  4.67
    8  Cell2          1   treated  5.55
    9  Cell2          2 untreated  4.23
    10 Cell2          2   treated  5.41
    11 Cell2          3 untreated  5.61
    12 Cell2          3   treated  7.69
    I have now to mention that I am not a statistician. After having a look, it seems that Two-way repeated-measures ANOVA would be the most appropriate test. Is it correct?

    I set the model like this: Value ~ Cell * Treatment + Error(Experiment/Treatment)

    and called
    Code:
    aov.out <- aov(Value ~ Cell * Treatment + Error(Experiment/Treatment), data=mydata)
    
    > summary(aov.out)
    
    Error: Experiment
              Df Sum Sq Mean Sq F value Pr(>F)
    Residuals  2  7.056   3.528               
    
    Error: Experiment:Treatment
              Df Sum Sq Mean Sq F value Pr(>F)  
    Treatment  1  62.38   62.38   11.28 0.0784 .
    Residuals  2  11.06    5.53                 
    ---
    Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
    
    Error: Within
                   Df Sum Sq Mean Sq F value Pr(>F)
    Cell            1  25.52  25.521   2.882  0.165
    Cell:Treatment  1  30.34  30.337   3.426  0.138
    Residuals       4  35.42   8.855

    But I am absolutely not sure about my model and I do not understand the output...

    Thanks in adavance,

    s.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I personally wouldn't use a random effect for something like this, there aren't enough samples taken in each group for it to be of much use (IMHO, though I'm sure there's a paper with suggestions regarding this). I'd just:

    Code:
    summary(aov(Value~Experiment+Treatment*Cell, df))
    Note that there's nothing that you can reasonably do to make the interaction p-value < 0.05, there's too much variance in cell1.

    Comment

    • SylvainL
      Senior Member
      • Feb 2012
      • 180

      #3
      Hi,

      So, to be sure, since what I want to see it whether the treatment as a different effect on the cell type, the pvalue I am insterested by is the Treatment:Cell. Is it correct?

      Code:
      > summary(aov(Value~Experiment+Treatment*Cell, mydata))
                     Df Sum Sq Mean Sq F value Pr(>F)  
      Experiment      2   8.13    4.07   0.515 0.6261  
      Treatment       1  62.84   62.84   7.958 0.0371 *
      Cell            1  23.58   23.58   2.986 0.1446  
      Treatment:Cell  1  37.20   37.20   4.711 0.0821 .
      Residuals       5  39.48    7.90                 
      ---
      Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
      Which in this case is not

      s.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        Correct. It's trending toward significance and might well get there, but more samples would be needed.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...